These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ovine Models of Congenital Heart Disease and the Consequences of Hemodynamic Alterations for Pulmonary Artery Remodeling. Johnson Kameny R; Datar SA; Boehme JB; Morris C; Zhu T; Goudy BD; Johnson EG; Galambos C; Raff GW; Sun X; Wang T; Chiacchia SR; Lu Q; Black SM; Maltepe E; Fineman JR Am J Respir Cell Mol Biol; 2019 May; 60(5):503-514. PubMed ID: 30620615 [TBL] [Abstract][Full Text] [Related]
5. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1. Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin. Van Hung T; Emoto N; Vignon-Zellweger N; Nakayama K; Yagi K; Suzuki Y; Hirata K Life Sci; 2014 Nov; 118(2):313-28. PubMed ID: 24412382 [TBL] [Abstract][Full Text] [Related]
8. ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport. Liu B; Azfar M; Legchenko E; West JA; Martin S; Van den Haute C; Baekelandt V; Wharton J; Howard L; Wilkins MR; Vangheluwe P; Morrell NW; Upton PD Cardiovasc Res; 2024 May; 120(7):756-768. PubMed ID: 38626311 [TBL] [Abstract][Full Text] [Related]
9. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension. Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428 [TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular pathobiology of pulmonary arterial hypertension. Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174 [TBL] [Abstract][Full Text] [Related]
11. Occlusive lung arterial lesions in endothelial-targeted, fas-induced apoptosis transgenic mice. Goldthorpe H; Jiang JY; Taha M; Deng Y; Sinclair T; Ge CX; Jurasz P; Turksen K; Mei SH; Stewart DJ Am J Respir Cell Mol Biol; 2015 Nov; 53(5):712-8. PubMed ID: 25879383 [TBL] [Abstract][Full Text] [Related]
12. Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage. Szulcek R; Happé CM; Rol N; Fontijn RD; Dickhoff C; Hartemink KJ; Grünberg K; Tu L; Timens W; Nossent GD; Paul MA; Leyen TA; Horrevoets AJ; de Man FS; Guignabert C; Yu PB; Vonk-Noordegraaf A; van Nieuw Amerongen GP; Bogaard HJ Am J Respir Crit Care Med; 2016 Jun; 193(12):1410-20. PubMed ID: 26760925 [TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Mandegar M; Fung YC; Huang W; Remillard CV; Rubin LJ; Yuan JX Microvasc Res; 2004 Sep; 68(2):75-103. PubMed ID: 15313118 [TBL] [Abstract][Full Text] [Related]
14. Regression of flow-induced pulmonary arterial vasculopathy after flow correction in piglets. Mercier O; Sage E; de Perrot M; Tu L; Marcos E; Decante B; Baudet B; Hervé P; Dartevelle P; Eddahibi S; Fadel E J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1538-46. PubMed ID: 19464477 [TBL] [Abstract][Full Text] [Related]
15. Circulating microparticles in severe pulmonary arterial hypertension increase intercellular adhesion molecule-1 expression selectively in pulmonary artery endothelium. Blair LA; Haven AK; Bauer NN Respir Res; 2016 Oct; 17(1):133. PubMed ID: 27765042 [TBL] [Abstract][Full Text] [Related]
17. The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models. Dickinson MG; Bartelds B; Borgdorff MA; Berger RM Am J Physiol Lung Cell Mol Physiol; 2013 Jul; 305(1):L1-14. PubMed ID: 23624788 [TBL] [Abstract][Full Text] [Related]
19. Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α. Dai Z; Li M; Wharton J; Zhu MM; Zhao YY Circulation; 2016 Jun; 133(24):2447-58. PubMed ID: 27143681 [TBL] [Abstract][Full Text] [Related]
20. Altered lymphatics in an ovine model of congenital heart disease with increased pulmonary blood flow. Datar SA; Johnson EG; Oishi PE; Johengen M; Tang E; Aramburo A; Barton J; Kuo HC; Bennett S; Xoinis K; Reel B; Kalkan G; Sajti E; Osorio O; Raff GW; Matthay MA; Fineman JR Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(6):L530-40. PubMed ID: 22207591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]